Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 271

1.

Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults.

Skjaerbaek C, Frystyk J, Møller J, Christiansen JS, Orskov H.

Eur J Endocrinol. 1996 Dec;135(6):672-7.

PMID:
9025711
2.

Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.

Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.

Clin Nephrol. 1999 Aug;52(2):103-9.

PMID:
10480221
3.

Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement.

Skjaerbaek C, Vahl N, Frystyk J, Hansen TB, Jørgensen JO, Hagen C, Christiansen JS, Orskov H.

Eur J Endocrinol. 1997 Aug;137(2):132-7.

4.

The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.

Frystyk J, Vinter-Jensen L, Skjaerbaek C, Flyvbjerg A.

Growth Regul. 1996 Mar;6(1):48-54.

PMID:
8717450
5.

No influence of prednisolone on IGFBP-3 proteolysis in healthy young men.

Dall R, Wolthers T, Flyvbjerg A, Grøfte T, Sandahl Christiansen J, Jørgensen JO.

Horm Res. 2001;55(2):95-101.

PMID:
11509866
7.
8.

Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.

Frystyk J, Ivarsen P, Skjaerbaek C, Flyvbjerg A, Pedersen EB, Orskov H.

Kidney Int. 1999 Dec;56(6):2076-84.

10.

The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.

Dall R, Longobardi S, Ehrnborg C, Keay N, Rosén T, Jørgensen JO, Cuneo RC, Boroujerdi MA, Cittadini A, Napoli R, Christiansen JS, Bengtsson BA, Sacca L, Baxter RC, Basset EE, Sönksen PH.

J Clin Endocrinol Metab. 2000 Nov;85(11):4193-200.

PMID:
11095453
11.

The IGF-I response to very low rhGH doses is preserved in human ageing.

Arvat E, Ceda G, Ramunni J, Lanfranco F, Aimaretti G, Gianotti L, Broglio F, Ghigo E.

Clin Endocrinol (Oxf). 1998 Dec;49(6):757-63.

PMID:
10209563
12.

Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.

Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.

Diabetes Metab Res Rev. 1999 Sep-Oct;15(5):314-22.

PMID:
10585616
13.

Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.

Carroll PV, Umpleby M, Alexander EL, Egel VA, Callison KV, Sönksen PH, Russell-Jones DL.

Clin Endocrinol (Oxf). 1998 Dec;49(6):739-46.

PMID:
10209561
14.
15.

Insulin-like growth factor I (IGF-I) and IGF-binding protein 3 response to growth hormone is impaired in HIV-infected children.

Rondanelli M, Caselli D, Aricò M, Maccabruni A, Magnani B, Bacchella L, De Stefano A, Maghnie M, Solerte SB, Minoli L.

AIDS Res Hum Retroviruses. 2002 Mar 20;18(5):331-9.

PMID:
11897034
16.

Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.

Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE.

J Clin Endocrinol Metab. 1999 Nov;84(11):4118-26.

PMID:
10566659
17.

Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.

Barreca A, Bozzola M, Cesarone A, Steenbergh PH, Holthuizen PE, Severi F, Giordano G, Minuto F.

J Clin Endocrinol Metab. 1998 Oct;83(10):3534-41.

PMID:
9768660
18.

No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.

Dall R, Lange KH, Kjaer M, Jørgensen JO, Christiansen JS, Orskov H, Flyvbjerg A.

J Clin Endocrinol Metab. 2001 Feb;86(2):669-74.

PMID:
11158029
19.

Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.

Christiansen JJ, Fisker S, Gravholt CH, Bennett P, Svenstrup B, Andersen M, Feldt-Rasmussen U, Christiansen JS, Jørgensen JO.

Eur J Endocrinol. 2005 May;152(5):719-26.

20.

Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.

Münzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, Blackman MR.

Am J Physiol Endocrinol Metab. 2006 May;290(5):E1006-13. Epub 2006 Jan 3.

Supplemental Content

Support Center